AEON.WS
AEON Biopharma, Inc. Warrants, each whole warrant exercisable to purchase one share of Class A Common Stock at an exercise price of $11.50 per share
AEON.WS
AEON.WS
Delisted
AEON.WS was delisted on the 26th of April, 2024.
40 hedge funds and large institutions have $851K invested in AEON Biopharma, Inc. Warrants, each whole warrant exercisable to purchase one share of Class A Common Stock at an exercise price of $11.50 per share in 2023 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 10 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
40
Holders Change
-2
Holders Change %
-4.76%
% of All Funds
0.64%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
5
Reduced
10
Closed
9
Calls
$60K
Puts
–
Net Calls
+$60K
Net Calls Change
+$107K
Top Buyers
| 1 |
AC
Athos Capital
Hong Kong
|
$143K |
| 2 |
SCM
Shaolin Capital Management
Miami,
Florida
|
$119K |
| 3 |
D.E. Shaw & Co
New York
|
$23.2K |
| 4 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
$8.03K |
| 5 |
LP
LMR Partners
London,
United Kingdom
|
$37.5K |
